Blood Test May Predict Relapse in Early-Stage Breast Cancer

Share this content:
An experimental blood test may one day detect the return of early-stage breast cancer months before it is revealed.
An experimental blood test may one day detect the return of early-stage breast cancer months before it is revealed.

An experimental blood test may one day detect the return of early-stage breast cancer months before it is revealed by computed tomography or magnetic resonance imaging, researchers report in Science Translational Medicine.

Nicholas Turner, M.D., Ph.D., of the Breakthrough Breast Cancer Research Centre at the Institute of Cancer Research in London, and colleagues studied 55 early-stage breast cancer patients who had undergone chemotherapy followed by surgery.

Blood samples were taken regularly for about two years after surgery to look for tumor-specific mutations in the patients' blood.

Fifteen patients eventually saw their cancer return. Of these, 12 were identified by the blood test about eight months before conventional imaging detected the cancer, the researchers reported. The noninvasive test was able to find metastatic tumors in all parts of the body except the brain.

RELATED: In Breast Cancer Survivors, Acupuncture Better Than Pills for Hot Flashes

This may mean that the blood-brain barrier prevents DNA in brain tumors from getting into the bloodstream, the authors said.

In some patients, the blood test found drug-resistant mutations. Knowing this, physicians can design treatments to target these mutations, Turner told HealthDay.

Reference

  1. Garcia-Murillas I, Schiavon G, Weigelt B, et al. Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer. Science Translational Medicine. 2015. DOI: 10.1126/scitranslmed.aab0021.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters